Table 4.
Effect of treatment on age and gender groups.
| Variables | Treat. +ve | Placeb. +ve | Treat. –ve | Placeb. –ve | P-value |
|---|---|---|---|---|---|
| Males PCR4 | 25 | 45 | 13 | 1 | <0.0001 |
| Females PCR4 | 17 | 54 | 45 | 0 | <0.0001 |
| Males PCR7 | 5 | 33 | 33 | 13 | <0.0001 |
| Females PCR7 | 22 | 32 | 46 | 16 | 0.001 |
| Males PCR 10 | 0 | 5 | 38 | 41 | 0.036 |
| Females PCR 10 | 1 | 5 | 61 | 49 | 0.064 |
| Young PCR 4 | 36 | 48 | 14 | 1 | 0.001 |
| Old PCR4 | 34 | 51 | 16 | 0 | <0.0001 |
| Young PCR 7 | 12 | 28 | 38 | 21 | 0.002 |
| Old PCR 7 | 9 | 37 | 41 | 14 | <0.0001 |
| Young PCR10 | 1 | 5 | 49 | 44 | 0.087 |
| Old PCR10 | 0 | 5 | 50 | 46 | 0.023 |
Displays the effect of the treatment on males and females, young and old age groups. Subgroup analysis was carried out by Chi-square testing. Young PCR, age group from 18–35 years; the old PCR, age group from 36 to 70. Treat, treatment; Placeb, Placebo; +ve, Positive; –ve, negative; PCR 4, 7, and 10, Polymerase chain reaction on day 4, 7, and 10 post-treatment.